NIH Cyclodextrin and HDAC Inhibitor Updates
Dear NNPDF Families and Friends,
The NNPDF central offices received an update from Dr. Forbes D. Porter to share with the community in regards to recent developments in both the Cyclodextrin and new Histone Deacetylase Inhibitors (HDACi) clinical trials.
Visit the Cyclodextrin Page: http://www.nnpdf.org/Cyclodextrin.html
Visit the HDACi Page: http://www.nnpdf.org/HDACi.html